Should the NHS be mixing vaccines for better effect, or at least offering people who have had one dose of the AstraZeneca vaccine the choice of having the Pfizer vaccine for their second shot?
The question arises because that is exactly the regime which has been followed in Germany since the risk of clotting from the AstraZeneca vaccine became evident.
Already a subscriber? Log in
Get 10 issues
for $10
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in